We constructed two recombinant Autographa californica nuclear polyhedrosis baculoviruses. Spodoptera frugiperda (Sf9) cells containing these constructs produce carboxy-terminally truncated envelope E proteins representing dengue (DEN) virus serotypes 2 and 3. The two recombinant proteins contained their homologous signal sequences at the N terminus and were truncated by 71 and 74 amino acids at the C terminus, respectively. This allowed the translocation of the recombinant proteins to the endoplasmic reticulum followed by glycosylation processing and secretion into the extracellular medium. An additional unglycosylated form which was not secreted was detected inside the infected Sf9 cells. Sera from Swiss mice immunized with the infected St9 cell lysates gave a DEN cross-reactive response in ELISA and substantial amounts of neutralizing antibodies to the homologous virus. Similar antibody titres were obtained when the two recombinant proteins were inoculated concomitantly. BALB/c mice were vaccinated with three doses of the recombinant E proteins, taken as monovalent or bivalent immunogens, and challenged with mouse-adapted DEN-2 virus. DEN-2 E protein induced a good protection (90 %) against lethal encephalitis and recombinant DEN-3 E protein gave a substantial cross-protection (54%). Eighty-two percent of the mice immunized with a mixture of both recombinant E proteins survived the DEN-2 virus challenge.
Introduction
Dengue (DEN) viruses are members of the family Flaviviridae transmitted by Aedes mosquitoes. They cause one of the major tropical diseases responsible for millions of cases of fever annually. DEN fever can progress to more severe symptoms, including DEN haemorrhagic fever (DHF) and DEN shock syndrome (DSS). DHF is characterized by increased vascular permeability and haemostasis disorders leading to hypovolemia which can result in DSS with a 30 to 40 % fatality rate . Factors contributing to severe outcomes of the disease are unknown. Strains with particular intrinsic features with respect to antigenic determinants, cell tropism, and regulation of virus replication and propagation may be involved in the pathology of the disease (Rosen, 1986) . Alternatively, the humoral immune response may play an important role in dengue infectivity: children in Southeast Asia who had a previous DEN virus infection developed cross-reactive non-neutralizing antibodies which may enhance infection by a second DEN serotype of mononuclear leukocytes harbouring Fc receptors (Halstead, 1988) .
The DEN complex contains four serotypes which can be distinguished from other flaviviruses such as yellow fever (YF), Japanese encephalitis (JE), and tick-borne encephalitis viruses by cross-neutralization tests (Calisher et al., 1989) . Vaccines are currently available against all these virus species except DEN. All these vaccines contain either purified and inactivated viruses or live attenuated variants (Stephenson, 1988) . To circumvent any possible enhancement of wild strains by cross-reactive antibodies at a sub-neutralizing level, potential DEN virus vaccines should elicit strong longlasting protection against all four serotypes. A vaccine based on live attenuated DEN viruses is undergoing trials in Thailand (Hunt, 1993) . Nevertheless, using four serotypes of live viruses may possibly lead to reversion to virulence, viral interference, and intergenomic recombination. Because of the serious medical impact of DEN in developing countries, the World Health Organization has been sponsoring a specific programme for DEN vaccine development, which focuses on new genetic engineering methods such as the expression of proteins by recombinant DNA technologies (Brandt, 1990) . DEN viruses contain a nucleoprotein (C), associated with a positive-sense genomic ssRNA of approximately 10750 bases. The nucleocapsid is surrounded by an envelope composed of two viral membrane proteins M and E which are embedded in a lipid bilayer from the rough endoplasmic reticulum. The genomic RNA encodes a single polyprotein starting with the sequence for C, followed by prM (precursor of M) and E. The proteins prM and E are generated by proteolytic processing at their amino termini mediated by host cell signalase in the rough endoplasmic reticulum. We have previously described the high yielding Autographa californica nuclear polyhedrosis virus (AcNPV)/Spodoptera frugiperda Sf9 cell genetic expression system for the production of DEN-2 virus proteins (Deubel et al., 1991) . When the recombinant DEN E protein was expressed in association with C and prM proteins, only E was detected in infected cells, suggesting that C and prM were unstable in the absence of non-structural viral proteins involved in the maturation of virus particles. In the absence of the viral protease complex NS2B-NS3 which cleaves the hydrophobic carboxy terminus of C protein, this protein remains membrane-associated, preventing formation of virion particles (Yamshchikov & Compans, 1993) .
In this study, two recombinant DEN E proteins were expressed independently from other viral proteins in the AcNPV/Sf9 system. The production of E proteins of DEN-2 and -3 serotypes from which the C-terminal anchor had been deleted (71 and 74 amino acids, respectively) was satisfactory. In addition, the proteins were able to induce protective immunity in mice infected with the two serotypes of virus.
Methods
Cells and viruses. Wild-type DEN virus strains used for recombinant gene expression (DEN-2, 1402/83 Jamaica, Jam; DEN-3, Pall881/88 Thailand, Thai) were propagated on Aedespseudoscutellaris (AP61) cell monolayers. DEN-2 (New Guinea C, NGC) and DEN-3 (H87) reference strains were used for serological tests. A mouse-adapted NGC strain (kindly provided by Dr N. Karabatsos) was used for mouse protection assays.
AP61 ceils were cultured at 28 °C in Leibovitz's L 15 medium (Gibco) supplemented with 10% fetal calf serum (FCS). Porcine kidney ceils (PS) were grown at 37 °C in Lt 5 medium containing 3 % FCS. Sf9 cells were cultured at 28 °C in Grace's medium (Gibco) supplemented with 10% FCS, 0.3% TC Yeastolate (Difco) and 0-3% lactalbumin hydrolysate (Gibco) following the procedure of Summers & Smith (1987) . AcNPV, AcRP23.1acZ [kindly provided by Drs D. H. L. Bishop and B. Kitts (Kitts et al., 1990; Possee & Howard, 1987) ] and recombinant baculoviruses were grown and assayed in Sf9 cells following previously described procedures (Summers & Smith, 1987) .
Cloning of the truncated DEN E genes. The gene coding for truncated DEN-2 E protein (D2Erec) was obtained by PCR amplification of a fragment of the DEN structural genes cloned in plasmid p30-VD2 (Deubel et al., 1986) , using oligonucleotides 5' 891GGCCTTGATT-TTCATCTTAC 3' and 5' CCCCATCCTCTGTCTACCATGlz21 3' as primers. Amplimers were given designations indicating the first nucleotide position in the published sequence of the DEN-2 Jam strain (Deubel et al., 1986) . These amplimers encompassed the sequences encoding the C-terminal 15 amino acids of prM which correspond to the signal sequence of E, and the N-terminal 102 amino acids of E. This last primer contained an Acc! site occurring naturally in the DEN-2 gene. PCR was used for amplification as described previously (Deubel et al., 1990) . PCR products were phosphorylated at their 5' ends (Maniatis et al., 1982) , and inserted into dephosphorylated Eco-RV-HinclI sites in plasmid pKS (pBluescript, Stratagene), generating the subclone pKS.D2Acc. Plasmid pAcYMI .D2SEs, described in Deubel et al. (1991) , contains the DEN-2 cDNA fragment encoding C, prM and all but the 71 carboxy-terminal amino acids of E. pAcYM 1. D2SEs was digested with AccI and XbaI, and the AccI-XbaI cDNA fragment was cloned into pKS. D2Acc digested with the same enzymes, to give pKS.D2Erec (Fig. 1) .
Genomic viral RNA was extracted from DEN-3 Thai-infected AP61 cells according to the method described previously (Deubel et al., 1990) . After reverse transcription, using the oligonucleotide 5'ATCCAAAGTCCCAGGCTGTG2179 3' as primer, cDNA was amplified using the same oligonucleotide and a second primer 5'ss s GAAAGTGGTTATTTTTATACTA 3'. Amplimers were given designations indicating the first nucleotide position in the published sequence of DEN-3 strain H87 (Osatomi & Sumiyoshi, 1990) . The PCR product encoding the truncated DEN-3 E protein (D3Erec) was inserted into dephosphorylated EcoRV-HinclI sites ofplasmid pKS, so that they generated initiation and stop codons at the extremities of the genes, respectively (Fig. 1) .
The recombinant subclones pKS.D2Erec and pKS.D3Erec were cleaved at EcoRI-XbaI and EcoRI-XhoI sites, respectively. The fragments were end-filled with the Klenow enzyme and inserted into the single BamHI site in pAcYM 1, which had been blunt-ended using the Klenow enzyme, and dephosphorylated (Fig. 1) .
DEN genes in recombinant shuttle plasmids pAc.D2Erec and pAc.D3Erec were sequenced using the dideoxynucleotide sequencing method (Circumvent, Biolabs). Thus the correct orientation of the truncated E-coding region relative to the polyhedrin gene promoter and the presence of the DEN E translation initiation and stop codons were verified.
Cotransfection and purification of recombinant baculoviruses. The
D2Erec and D3Erec genes cloned in pAc. D2Erec and pAc. D3Erec, respectively, were transferred into the AcRP23.1acZ genome by homologous recombination. The p-galactosidase gene was replaced by recombinant DEN genes, using a modification of the procedure described by Kitts et at. (1990) . Sf9 cells were cotransfected with 100 ng of AcRP23. lacZ DNA linearized at the single Bsu36I site and 10 Ixg of recombinant transfer vector, using the Upofectin-mediated transfection method (DOTAP, Boehringer Mannheim). Recombinant viruses in the transfected cell supernatants were plaque-purified three times.
Radioimmunoprecipitation assay (RIPA).
This was carried out as described in a previous study (Deubel et al., 1991) . Sf9 cells infected at a multiplicity of 10 p.f.u, per cell with different baculoviruses were labelled with 100 ~tCi of [35S]methionine per ml 24 h post-infection (p.i.) for 4 h. Infected cells were lysed in 1 ml per l0 s cells of RIPA buffer (50 mM-Tris--HCl pH 7'5, 150 mM-NaC1, 10 mM-EDTA, 0"1% SDS, 1% Triton X-100, 1% sodium deoxycholate). Recombinant DEN E proteins were precipitated with 2 ~tl of hyperimmune mouse ascitic fluid (HMAF). The immune complexes were collected on Protein A-Sepharose beads and washed three times with buffer A (10 mM-Tris-HC1 pH 7'5, 150 mM-NaCI, 0.2% NP40, 2 mM-EDTA), twice with buffer B (10mM-Tris-HC1 pH 7"5, 500mM-NaC1, 0.2% NP40, 2 mM-EDTA), and once with buffer C (10 mM-Tris-HC1 pH 7.5). The beads were then resuspended in sample buffer (Laemmli, 1970) . The suspension was boiled for 1 rain, the beads were pelleted, and the supernatants were analysed by 14 % SDS-PAGE and fluorography.
Immunoblot analysis. Total cell proteins were extracted 48 h p.i. in sample buffer. Proteins from 2 × 105 cells were electrophoresed on a 10 % SDS-polyacrytamide gel and electrophoretically transferred onto nitrocellulose membranes. The membranes were treated with incubation buffer (50 mM-Tris-HC1 pH 7'5, 500 mM-NaC1) containing 5 % non-fat dried milk and then incubated overnight at 4 °C with a 1 : 100-fold dilution of human pooled sera or with a 1 : 10000 dilution of anti-E subcomplex-specific monoclonal antibody (MAb) E2A10 (kindly provided by Dr P. J. Wright). The bound antibodies were detected by incubation of the membranes with alkaline phosphataseconjugated anti-human and anti-mouse IgG (Biosys), respectively.
Immunization of mice. Infected Sf9 cells were pelleted, washed once in sterile PBS (pH 7'4), resuspended in PBS at a concentration of 5 x 106 cells/ml, and finally sonicated at 60 W for 2 min. Groups of 12 3-week-old female Swiss mice were immunized by intraperitoneal injection on days 0, 13, 28 and 112 either with 200 pl of infected Sf9 cell extracts, or with approximately l0 s p.f.u, of DEN-2 Jam or DEN-3 Thai live viruses. Immunized mice were bled on days 11, 26, 46, 110, 126 and 208 , and the sera were tested by ELISA and neutralization tests.
Induction of protection to experimental DEN encephalitis was evaluated in 3-week-old female BALB/c mice (IFFA Credo) immunized by the intraperitoneal route on days 0, 7 and 21 either with 200 pl of infected cell extracts or with live DEN-2 and DEN-3 reference strains. Mice were bled on day 26 and challenged on day 28 by intracerebral inoculation of 100 LDs0 of the mouse-adapted DEN-2 NGC strain and observed for 1 month for symptoms of encephalitis and mortality.
Plaque reduction neutralization test (PRNT). Sera collected from
immunized mice at days 110 and 126 were pooled and serially diluted in twofold steps from 1 : 5 to 1 : 160, distributed into 24-well plates and incubated with 50 p.f.u, of the DEN-2 NGC or DEN-3 H87 strains. Suspensions of PS cells (approximately 8 x 104 cells per well) in L15 medium supplemented with 3 % FCS were added to each well and the plates incubated at 37 °C for 4 h. An equal volume of 2 % carboxymethylcellulose suspension in L15 supplemented with 3% FCS was then added to each well. After 6 days of incubation at 37 °C, PS ceils were rinsed with PBS, fixed with a 10% formol solution in PBS and then permeabilized with 0-5 % Triton X-100 in PBS. Focus staining was carried out by successive incubations of cell layers at 37 °C for 1 h with HMAF (1:100 in PBS) followed by goat peroxidase-labelled antimouse IgG (Biosys). The staining solution (300 pl of 0"05 % 3,3'-diaminobenzidine tetrahydrochloride, 0"3% H202, 0-1 M-Tris-HC1 pH 7-6) was then added to each well. The reaction was stopped by adding 200 pl of 1 M-H2SO 4. Stained cell foei were observed under a microscope. Neutralizing serum titres were determined as dilutions yielding a 50 % reduction in the number of plaques.
ELISA. Microtitre plates (Dynatech M 129 B) were coated overnight at 4 °C with pooled human anti-DEN sera diluted 1 : 500 in PBS. The plates were incubated at 37 °C for 3 h with 2 haemagglutination units of DEN-2-or DEN-3-specific antigens prepared from suckling mouse brain as previously described (Barme et aL, 1970) , and diluted in PBS supplemented with 0'5 % Tween 20, 1% non-fat dried milk. The plates were washed in supplemented PBS, a 1:100 dilution of pooled immunized mouse sera was added and the plates were incubated for 1 h at 37 °C. The wells were washed with diluting buffer and antibodies were detected by an additional incubation of the plates with a 1 : 3000 dilution of peroxidase-labelled anti-mouse IgG (Biosys). After washing, bound enzyme-linked secondary antibodies were detected using tetramethylbenzidine as the substrate.
Results

Construction of recombinant transfer vectors
Genes encoding the truncated DEN-2 and DEN-3 envelope E proteins were inserted into the transfer vector pAcYM1 (Matsuura et al., 1987) at the BamHI site, so that the recombinant genes were under the control of the AcNPV polyhedrin promoter (Fig. 1) . The correct orientation of the inserts in the recombinant transfer vectors (pAc.D2Erec and pAc.D3Erec), and the sequences between the ATG of the DEN genes and the polyhedrin transcription initiation site were verified by sequence analysis. The altered polyhedrin start codon was followed by 12 nucleotides before the first ATG codon, which was the initiation codon for the signal sequences (15 amino acids long in D2Erec and 16 amino acids long in D3Erec) of the DEN E proteins. It has been shown for YF virus that the 15 amino acids preceding the E protein in the polyprotein precursor function as a signal peptide (Despr~s et al., 1988) . Termination codons were introduced by the constructions (described in Methods) after amino acid 424 in the DEN-2 E protein and 421 in the DEN-3 E protein, leading to proteins lacking their C-terminal 71 and 74 amino acids, respectively. The position of the stop codon downstream of the DEN-2 E protein construct resulted in two extra residues (1-425 and L-426) from vector sequences being included (Deubel et al., 1991) .
The entire DEN-derived sequences in recombinant shuttle plasmids were determined. The nucleotide sequence of the D2Erec gene was identical to that previously determined from clone p30-VD2 (Deubel et al., 1986) . There were 57 nucleotide differences in the 1263 nucleotides (4.5 %) of the truncated DEN-3 E gene of the Pall881 strain as compared to the H87 reference strain (Osatomi & Sumiyoshi, 1990) . Only two transversions were observed and differences were mostly in the third position of codons: the encoded amino acids were different at only nine of the 421 positions in the truncated sequence (Table 1) . The shuttle vectors pAc.D2Erec and pAc.D3Erec
were cotransfected with linearized AcRP23. lacZ DNA into Sf9 cells, and recombinant baculoviruses AcD2Erec and AcD3Erec, respectively, were obtained after plaque experiments. The presence of the DEN E genes at the expected size in both baculoviruses was verified by PCR amplification of DNA in the supernatants.
Expression and biochemical features of D2Erec and D3Erec proteins in S[9 cells
Confluent monolayers of Sf9 ceils were infected at a multiplicity of 1 p.f.u, per cell with AcNPV, AcD2Erec or AcD3Erec viruses. Protein products were harvested 48 h p.i., resolved by SDS-PAGE and analysed by direct staining of the gel (Fig. 2 a) and by Western blotting after transfer to nitrocellulose (Fig. 2b, c) . At least two major species were detected in AcD2Erec-and AcD3Erec-infected cells. The apparent M r values of D2Erec (56K and 52K) were higher than those of D3Erec (55K and 51K). The two major species reacted either with pooled human sera or with the subcomplex-specific MAb E2A10, indicating that these two recombinant antigens were DEN virus-specific. The yield of the recombinant proteins produced in insect cell cultures was about 10 to 20 ~tg per 106 cells (Fig. 2a) , as estimated by comparison with known amounts of BSA stained with Coomassie blue.
The recombinant E proteins were truncated forms, not containing the C-terminal anchor part; we therefore determined their secretion status. Sf9 cells infected with AcD2Erec or AcD3Erec viruses were labelled with 100 ~tCi of [35S]methionine per ml, 24 h p.i. for 4 h. Supernatants were collected and, as the infected cell lysates, precipitated with DEN-specific HMAF. The precipitates were analysed by PAGE (Fig. 3) . Only the high molecular weight (HMW) forms were found in the extracellular media. After treatment with endoglycosidase F, the sensitive products had sizes similar to the low molecular weight (LMW) forms (data not shown).
These data suggest (i) that the H M W forms represent the N-glycosylated states (with approximately 2K added per site), (ii) that the LMW forms are unglycosylated proteins and (iii) that only the glycosylated recombinant proteins are secreted across the plasma membrane. Deubel et al., 1991) . The protocol was similar to that used previously for immunization studies using baculovirus-expressed DEN-1 E protein (Putnak et al., 1991) . Lysates of baculovirus recombinant-infected cells were administered without Freund's adjuvant because it did not appear to be of any value in similar experiments with recombinant DEN-4 proteins (Zhang et al., 1988) . Pooled mouse sera were examined by ELISA at various times after a series of three vaccinations. After the first immunization (day 0) the antibody response against the homologous antigen was detected on day 11; it was higher after the second immunization on day 26, higher still after the third inoculation on day 46 and still high on day 110 (Fig. 4) . A fourth boost given on day 112 seemed to induce an anamnestic response when DEN-2 antigen was inoculated. Antibody titres remained at similar levels 3 months (day 208) after the fourth boost. The levels of antibody response after three and four immunizations with either recombinant DEN E proteins or DEN-2 and DEN-3 live viruses were comparable (data not shown). Sera from mice inoculated with a bivalent vaccine preparation were tested against DEN-2 and -3 antigens. The antibody response against both antigens was similar to that obtained against the homologous antigen after immunization with a single recombinant DEN E protein (Fig. 4) . Nevertheless, we were not able to differentiate type-specific from cross-reactive antibodies because DEN virus-infected suckling mouse brain was used as a crude antigen preparation in ELISA. To determine neutralization titres in the immunized mouse sera, PRNT assays were carried out 3 months after the third inoculation (day 110) and 2 weeks after the fourth inoculation (day 126) ( Table 2) . Neutralizing antibodies to homologous virus were induced by the recombinant DEN E proteins and reached a significant level (titres 1 : 10 to 1:40) after four series of immunization. Inclusion of both recombinant D2Erec and D3Erec proteins in the vaccine preparation seemed to produce levels of neutralizing antibodies (titres 1:10 to 1:80) that were equivalent or slightly higher than those induced by single protein immunization. Sera from mice either infected with live DEN-2 and DEN-3 viruses or vaccinated with * Serum dilutions yielding 50 % reduction in the number of plaques. t Sample sera collected 2 days before (day 110) and 14 days after (day 126) the fourth inoculation.
Immunization of mice and serological analyses
:~ Nr, Not tested. * Three-week-old BALB/c mice were immunized with three intraperitoneal injections of either DEN live viruses or infected Sf9 cell lysates. Vaccinated mice were challenged intracerebrally with 100 LDs0 of the mouse-adapted DEN-2 NGC strain. t P < 0-001 when compared to Sf9/baculovirus. recombinant E proteins showed similar PRNT titres. The low titre of neutralizing antibodies observed with live viruses may be due to the low replication rate of the non-mouse-adapted viruses used to infect mice.
Mouse protection assay
The ability of recombinant D2Erec and D3Erec proteins to protect mice against mortality due to DEN-2 virus encephalitis was determined after vaccination of 3-weekold BALB/c mice at days 0, 7 and 21 with crude cell extract preparations as indicated above. These inbred mice were chosen for protection studies because they are the only strain susceptible to the mouse-adapted DEN-2 NGC strain. As a negative control group, mice were immunized with lysates from insect ceils infected with AcRP23.1acZ. A third, positive control group of mice was immunized with DEN-2 Jam and DEN-3 Thai live viruses. One week after the last immunization, mice were challenged intracerebrally with 100 LDs0 of DEN-2 strain NGC. There is no mouse-adapted DEN-3 virus strain available that kills 7-week-old mice when administered by the intracerebral route. The recombinant D2Erec protein induced a substantial protection against DEN encephalitis: 90% of mice resisted the DEN-2 virus challenge (Table 3) . A protection of 82 % was observed when BALB/c mice were vaccinated with a mixture of D2Erec and D3Erec proteins. Mice immunized with AcD3Erec-infected cell extracts showed a low cross-protection rate (54%) against heterologous DEN-2 virus. Nevertheless, there appears to be no crossreaction after immunization with live DEN-3 virus (33 % compared to 21% for the negative control).
Discussion
This study shows that two recombinant E proteins derived from serotypes 2 and 3 of DEN virus can induce anti-viral neutralizing antibodies and protective immunity when used together to inoculate mice. These two antigens were truncated at their C termini because we had demonstrated that a DEN-2 E protein with a truncation corresponding to the 71 amino acids at the C terminus of the native protein was synthesized at a higher level and is more soluble than the membrane-anchored protein (Deubel et al., 1991) . Similar results have been obtained for recombinant vaccinia virus-expressed DEN-4 virus E protein: the protein lacking the C-terminal 20 % was expressed more efficiently on the cell surface than the full-length E protein (Men et al., 1991) . Moreover, the truncated protein induced higher titres of antibody and protected mice against intracerebral challenge. The DEN-2 E gene fragment was derived from a previous construct (Deubel et al., 1991) and a full-length PCR amplicon was cloned for DEN-3 gene expression. The constraints of cloning were such that the first 424 amino acids of DEN-2 and 421 amino acids of DEN-3 E proteins were used. The yield of the two proteins was similar, approximately 10 to 20 lag per l0 s cells, which is two-to fourfold higher than that of native protein produced in association with C and prM proteins (Deubel et al., 1991) . Nevertheless, the increased yield of recombinant protein was accompanied by incomplete glycosylation. Incomplete type oligosaccharides have been reported for numerous glycoproteins produced in the AcNPV/S9 system . We had previously demonstrated that the secretion of the protein was delayed by approximately 4 h and that the unglycosylated precursor of the recombinant protein was not secreted (Deubel et al., 1991) . We have confirmed in this study that only the complete N-glycosylated forms of the recombinant E proteins were secreted into the extracellular medium. Truncated DEN-1 and -4 E proteins produced from baculovirus are not secreted (Lai et al., 1989; Putnak et al., 1991) . The truncated DEN-1 E protein was preceded by 36 amino acids of the M protein and the truncated DEN-4 E protein contained the signal sequence from the E protein of respiratory syncytial virus. It has been suggested that the absence of secretion was due to the inappropriate length or nature of the signal sequence which could not be cleaved properly, thus leaving the proteins anchored in cell membranes by their hydrophobic N-terminal region (Lai et al., 1989) . Our results confirm that a 15 or 16 amino acid signal at the N terminus of DEN E proteins appears to be appropriate for E protein translocation and cleavage by cellular signalase in the endoplasmic reticulum (Ruiz-Linarts et al., 1989) .
The capacity of recombinant DEN-1 and -4 proteins from the lysate of baculovirus-infected cells to induce immune protection in vaccinated mice (Zhang et al., 1988; Lai et al., 1989; Putnak et al., 1991) suggested the possibility of mouse immunization using lysates containing DEN-2 and -3 virus recombinant proteins. Flavivirus-neutralizing antibodies, even at low titres, are believed to reflect a protective immunity status against infection by a homologous virus (Putnak et al., 1991) . Our experiments provide evidence that mice are protected against lethal DEN-2 infection by immunization with DEN-2-specified recombinant E protein in cell lysates inoculated either individually or in association with lysates containing DEN-3-specified recombinant E protein. Since the amount of serum obtained from each mouse was small, only pooled sera were tested in PRNT. Therefore, it was not possible to establish a relationship between the titre of neutralizing antibodies and survival in the mice. Antibodies have been raised against type-, complex-and group-specific determinants present on the DEN E protein (Fig. 4 and Table 2 ). It has been suspected that enhancement of virus growth in macrophages during heterotypic secondary infection could be mediated by circulatory cross-reactive non-neutralizing antibodies which thereby contribute to the pathogenesis of DHF/DSS (Halstead, 1988) . Therefore, the presence of homotypic neutralizing antibodies obtained at a substantial level after the fourth inoculation (Table 2) might be advantageous in preventing such immunopathological manifestations. There are genetic and antigenic variations between different strains of DEN virus (Chungue et al., 1993; Monath et al., 1986; RicoHesse, 1990 ). DEN-2 Jam-and DEN-3 Thai-derived E proteins show 3.9 % (Gruenberg et al., 1988) and 2.1% amino acid divergence from their respective DEN-2 NGC and DEN-3 H87 reference strains used as sources of antigens. It is unclear whether the divergence between the two DEN-2 E proteins accounts for the lower titre of neutralizing antibody when compared to those obtained with DEN-3 viruses (Table 2 ). There may be other reasons for the superior immunogenicity of the D3Erec protein. Neutralizing antibodies induced by inactivated JE vaccine reacted to almost the same extent with nine different virus strains (Okuno et aL, 1987) . Therefore, it would be valuable to determine whether neutralizing antibodies induced by our vaccine preparation efficiently recognize different DEN virus genotypes. D2Erec protein induced a good protection (90%) in BALB/c mice against DEN-2 encephalitis. No neutralizing antibodies were detected in the sera of vaccinated mice prior to the challenge (data not shown). Fifty-four percent of mice vaccinated with the D3Erec immunogen were protected against DEN-2 encephalitis. Beneficial cross-protective antibody against DEN has been suggested previously from studies of JE vaccination (Hoke et al., 1988) . Therefore, cross-reactive neutralizing antibodies that are short-lasting but nevertheless present within the period of the protection test may assure partial protection against the heterologous virus. On the other hand no cross-protective cellular immune response to the E protein has been demonstrated (Rothman et al., 1993) . Cross-protective immunity induced by D2Erec and D3Erec against DEN-I and -4 serotypes has not been investigated but will be analysed when the four recombinant E proteins are available.
It has been suggested that antibodies against NS 1 may contribute to cross-protection via a mechanism of immune-mediated cytolysis of infected cells (Schlesinger et al., 1990) . DEN-4 recombinant E protein produced alone or concomitantly with NS1 induced a similar protective immunity in mice against DEN encephalitis (Lai et al., 1989) . Although mice immunized with flavivirus-specified recombinant E and NS1 proteins produced from baculovirus demonstrated antibody response against E and NS1, they were generally not protected but there was a trend towards increased survival time (Despr~s et al., 1991 ; McCown et al., 1990) . Coproduced flavivirus prM and E proteins associate to form highly immunogenic virus-like particles which are secreted from recombinant vaccinia virus-infected cells (Yasuda et al., 1990; Mason et al., 1991; Pincus et al., 1992; Fonseca et al., 1994) . Our results suggest that the DEN E proteins, truncated by 15 % of their length in the C-terminal anchor region, can be processed and secreted in the absence of other viral proteins (Men et al., 1991 ; Jan et al., 1993) . Truncated DEN-2 and -3 proteins in recombinant virus vaccine preparations appear to adopt a conformation suitable for the induction of neutralizing antibodies and protective immunity in mice against homologous DEN virus. Moreover, the baculovirus expression system yields sufficient E protein to suggest that purification is feasible although suitable procedures remain to be established. Thus, truncated DEN E proteins produced from baculovirus are promising candidates for recombinant virus vaccines. Recombinant E proteins from serotypes 1 and 4 will be produced with particular emphasis on developing purification processes for the secreted proteins. The aim is to develop a tetravalent subunit DEN vaccine for use in humans.
